Selank vs NA Selank Amidate: Which Version and Why?
Written by NorthPeptide Research Team | Reviewed December 24, 2025
Research Disclaimer: This article is for educational and informational purposes only. All peptides discussed are for laboratory and research use only. Not for human consumption. Always consult a qualified healthcare professional.
Selank and NA Selank Amidate are both derived from the same tuftsin-based structure, but NA Selank Amidate adds N-acetylation and C-terminal amidation for improved stability and potency. Understanding the structural differences helps researchers choose the right version for their experimental goals — and explains why these are considered distinct compounds rather than interchangeable.
By the NorthPeptide Research Team
What Is Selank?
Selank is a synthetic anxiolytic peptide developed in Russia by the Institute of Molecular Genetics. It is based on tuftsin (Thr-Lys-Pro-Arg), a naturally occurring tetrapeptide that modulates immune function, with a Pro-Gly-Pro (PGP) extension added to stabilize the molecule. The resulting heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, is Selank.
Selank was developed primarily as an anti-anxiety (anxiolytic) and nootropic compound. It received regulatory approval in Russia and Ukraine as a drug for anxiety and asthenia (fatigue/weakness). Research shows it modulates GABA activity, influences BDNF expression, and affects serotonergic and dopaminergic systems without the dependence and sedation associated with benzodiazepines.
What Is NA Selank Amidate?
NA Selank Amidate is a chemically modified form of Selank incorporating the same modifications used in NA Semax Amidate:
- N-acetylation: An acetyl group is added to the N-terminus, protecting against aminopeptidase degradation
- C-terminal amidation: The free carboxyl group at the C-terminus is replaced with an amide group, mimicking naturally occurring neuropeptide structure and providing resistance to carboxypeptidase degradation
The result is a structurally distinct compound with different pharmacokinetic properties despite sharing the same biological targets as standard Selank.
How the Modifications Change the Compound’s Behavior
Metabolic Stability
Both N-acetylation and C-terminal amidation reduce the rate at which the peptide is degraded by proteolytic enzymes in plasma and at biological surfaces. Standard Selank has a relatively short half-life — measured in minutes in plasma. The modifications in NA Selank Amidate extend this, reducing the dose frequency required to maintain biological activity in experimental models.
Blood-Brain Barrier Penetration
N-acetylation increases the lipophilicity of the peptide, which generally improves its ability to cross the blood-brain barrier. Since Selank’s primary targets are in the central nervous system — the GABAergic system, BDNF expression, and serotonergic pathways — improved CNS penetration is directly relevant to its research profile.
Receptor Binding Affinity
C-terminal amidation is a common feature of bioactive neuropeptides and is associated with enhanced receptor binding in many cases. For Selank-derived compounds, the precise effect on receptor affinity has not been fully characterized in published literature, but the structural principle is well established across neuropeptide pharmacology.
Shared Mechanisms
Both Selank and NA Selank Amidate share the following research-documented activities:
- Anxiolytic activity: Modulation of GABA-A receptor function, producing anxiety reduction without benzodiazepine-like sedation or dependence in animal models
- BDNF upregulation: Increased brain-derived neurotrophic factor expression, supporting neuroplasticity and neuroprotection
- Serotonin and dopamine modulation: Effects on monoamine systems relevant to mood and cognition
- Immune modulation: Derived from tuftsin, Selank retains some immunomodulatory properties, including effects on IL-6 and interferon activity
- Nootropic properties: Improved learning and memory in animal models
View Selank →
View NA Selank Amidate →
Choosing Between Versions for Research
Standard Selank is better supported by published literature — the Russian regulatory trials and subsequent academic research used the standard form. For replication studies or research that needs to align with existing published protocols, standard Selank is the more defensible choice.
NA Selank Amidate is preferred by researchers who want to study the effect of structural modifications on activity, or who are working with models where longer half-life or reduced dosing frequency is experimentally desirable. The enhanced potency per milligram means dose calculations need adjustment.
Comparison Table
| Feature | Selank | NA Selank Amidate |
|---|---|---|
| Base structure | Tuftsin+PGP | N-Ac-Tuftsin+PGP-NH2 |
| Metabolic stability | Moderate | Higher |
| Relative potency | Standard | Higher per mg |
| Published research | Larger body | Smaller, emerging |
| Regulatory history | Approved in Russia/Ukraine | Research compound only |
References
| Author(s) | Title | Source |
|---|---|---|
| Semenova TP et al. | Selank and Tuftsin Affect Serotonin Metabolism in the Brain of Rats | Bull Exp Biol Med, 2009 |
| Uchakina ON et al. | Immunomodulatory Effects of Selank in Patients with Anxiety | Zh Nevrol Psikhiatr Im S S Korsakova, 2008 |
| Mjaaseth RR et al. | Structural Modifications of Neuropeptides and Their Impact on CNS Activity | J Pept Sci, 2018 |
Disclaimer: This content is for research and educational purposes only. Not medical advice. All peptides are for laboratory use only and not intended for human consumption.